The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular risk.
This was the timely topic debated by Dr Allan Sniderman (protagonist) and Dr Jacques Genest Jr (antagonist) at the ninth internation symposium on atherosclerosis, October 7, 1991, in Chicago-Rosemont, Illinois. Dr Maurice Mishkel, Professor Emeritus and founder of the McMaster Lipid Research Clinic moderated the event which was made possible by an educational grant from Sandoz Canada.
Sniderman
A D
AD
Cardiology Division, Royal Victoria Hospital, Montreal, Quebec.
D001055:Apolipoproteins B / Q000032:analysis*; D002170:Canada; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D008055:Lipids / Q000097:blood*; D008403:Mass Screening / Q000379:methods*; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D014280:Triglycerides